UnitedHealth (UNH) Stock Forecast & Price Target

Compare

23,216 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

UNH Analyst Ratings

Strong Buy

16 Buy

2 Hold

0 Sell

Based on 18 analysts giving stock ratings to

UnitedHealth

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

UNH Stock 12 Month Forecast

Average Price Target

$372.94

▲(30.59% Upside)

Based on 18 Wall Street analysts offering 12 month price targets for UnitedHealth in the last 3 months. The average price target is $372.94 with a high forecast of $440.00 and a low forecast of $311.00. The average price target represents a 30.59% change from the last price of $285.59.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"233":"$233","530":"$530","307.25":"$307.3","381.5":"$381.5","455.75":"$455.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":440,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$440.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":372.94,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$372.94</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":311,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$311.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[233,307.25,381.5,455.75,530],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"May<br/>2025","6":"Aug<br/>2025","9":"Nov<br/>2025","12":"Feb<br/>2026","25":"Feb<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,285.59,297.4676923076923,309.3453846153846,321.2230769230769,333.10076923076923,344.97846153846154,356.8561538461538,368.7338461538461,380.61153846153843,392.48923076923074,404.36692307692306,416.2446153846154,428.1223076923077,{"y":440,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,285.59,292.30923076923074,299.0284615384615,305.7476923076923,312.4669230769231,319.18615384615384,325.9053846153846,332.62461538461537,339.34384615384613,346.0630769230769,352.78230769230765,359.5015384615385,366.22076923076924,{"y":372.94,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,285.59,287.5446153846154,289.49923076923073,291.45384615384614,293.4084615384615,295.3630769230769,297.3176923076923,299.27230769230766,301.2269230769231,303.1815384615385,305.13615384615383,307.09076923076924,309.0453846153846,{"y":311,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":529.45,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 57,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":463.54,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 47,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":512.73,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 55,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":392.72,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 65,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":298.67,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 73,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":321.93,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 62,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":234.7,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 47,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":304.81,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 47,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":345.97,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 52,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":339.28,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 47,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":321.05,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 35,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":330.11,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":285.59,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$440.00

Average Price Target$372.94

Lowest Price Target$311.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Jessica Tassan

Piper Sandler

$396→$390

Buy

36.56%

Upside

Reiterated

02/03/26

Analysts Offer Insights on Healthcare Companies: TransMedics Group (NASDAQ: TMDX), UnitedHealth (NYSE: UNH) and Johnson & Johnson (NYSE: JNJ)

David S Macdonald

Truist Financial

$410→$370

Buy

29.56%

Upside

Reiterated

02/02/26

Analysts Conflicted on These Healthcare Names: UnitedHealth (NYSE: UNH), CytomX Therapeutics (NASDAQ: CTMX) and Beta Bionics, Inc. (NASDAQ: BBNX)

Lisa Gill

J.P. Morgan

$425→$389

Buy

36.21%

Upside

Reiterated

02/02/26

UnitedHealth price target lowered to $389 from $425 at JPMorganUnitedHealth price target lowered to $389 from $425 at JPMorgan

Stephen Baxter

Wells Fargo

$400→$370

Buy

29.56%

Upside

Reiterated

01/30/26

UnitedHealth price target lowered to $370 from $400 at Wells FargoUnitedHealth price target lowered to $370 from $400 at Wells Fargo

Lance Wilkes

Bernstein

$444→$405

Buy

41.81%

Upside

Reiterated

01/29/26

UnitedHealth (UNH) Gets a Buy from Bernstein

Andrew Mok CFA

Barclays

$391→$327

Buy

14.50%

Upside

Reiterated

01/29/26

Analysts Offer Insights on Healthcare Companies: UnitedHealth (NYSE: UNH), Cytokinetics (NASDAQ: CYTK) and Moderna (NASDAQ: MRNA)

Ryan Langston

TD Cowen

$338→$311

Hold

8.90%

Upside

Reiterated

01/29/26

Analysts Offer Insights on Healthcare Companies: AbbVie (NYSE: ABBV) and UnitedHealth (NYSE: UNH)

Erin Wright

Morgan Stanley

$409→$375

Buy

31.31%

Upside

Reiterated

01/28/26

UnitedHealth: Buy Rating Reaffirmed on Resilient Earnings, Margin Discipline, and Long-Term Growth Despite Medicare Policy Headwinds

Michael Wiederhorn

Oppenheimer

$415→$385

Buy

34.81%

Upside

Reiterated

01/28/26

UnitedHealth price target lowered to $385 from $415 at OppenheimerUnitedHealth price target lowered to $385 from $415 at Oppenheimer

David Windley

Jefferies

$340

Buy

19.05%

Upside

Reiterated

01/28/26

Jefferies Sticks to Their Buy Rating for UnitedHealth (UNH)

A.J. Rice

UBS

$430→$410

Buy

43.56%

Upside

Reiterated

01/28/26

UnitedHealth price target lowered to $410 from $430 at UBSUnitedHealth price target lowered to $410 from $430 at UBS

Sarah James

Cantor Fitzgerald

$440

Buy

54.07%

Upside

Reiterated

01/28/26

Cantor Fitzgerald Keeps Their Buy Rating on UnitedHealth (UNH)

Matthew Gillmor CFA

KeyBanc

$400

Buy

40.06%

Upside

Reiterated

01/28/26

Analysts Offer Insights on Healthcare Companies: UnitedHealth (NYSE: UNH), HCA Healthcare (NYSE: HCA) and Cardiff Oncology (NASDAQ: CRDF)

Ben Hendrix

RBC Capital

$408→$361

Buy

26.40%

Upside

Reiterated

01/27/26

Analysts' Top Healthcare Picks: AbbVie (ABBV), Maze Therapeutics, Inc. (MAZE)

Kevin Fischbeck

Bank of America Securities

$410→$315

Hold

10.30%

Upside

Reiterated

01/27/26

2027 rate notice likely pushing UnitedHealth lower, says BofA2027 rate notice likely pushing UnitedHealth lower, says BofA

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Jessica Tassan

Piper Sandler

$396→$390

Buy

36.56%

Upside

Reiterated

02/03/26

Analysts Offer Insights on Healthcare Companies: TransMedics Group (NASDAQ: TMDX), UnitedHealth (NYSE: UNH) and Johnson & Johnson (NYSE: JNJ)

David S Macdonald

Truist Financial

$410→$370

Buy

29.56%

Upside

Reiterated

02/02/26

Analysts Conflicted on These Healthcare Names: UnitedHealth (NYSE: UNH), CytomX Therapeutics (NASDAQ: CTMX) and Beta Bionics, Inc. (NASDAQ: BBNX)

Lisa Gill

J.P. Morgan

$425→$389

Buy

36.21%

Upside

Reiterated

02/02/26

UnitedHealth price target lowered to $389 from $425 at JPMorganUnitedHealth price target lowered to $389 from $425 at JPMorgan

Stephen Baxter

Wells Fargo

$400→$370

Buy

29.56%

Upside

Reiterated

01/30/26

UnitedHealth price target lowered to $370 from $400 at Wells FargoUnitedHealth price target lowered to $370 from $400 at Wells Fargo

Lance Wilkes

Bernstein

$444→$405

Buy

41.81%

Upside

Reiterated

01/29/26

UnitedHealth (UNH) Gets a Buy from Bernstein

Andrew Mok CFA

Barclays

$391→$327

Buy

14.50%

Upside

Reiterated

01/29/26

Analysts Offer Insights on Healthcare Companies: UnitedHealth (NYSE: UNH), Cytokinetics (NASDAQ: CYTK) and Moderna (NASDAQ: MRNA)

Ryan Langston

TD Cowen

$338→$311

Hold

8.90%

Upside

Reiterated

01/29/26

Analysts Offer Insights on Healthcare Companies: AbbVie (NYSE: ABBV) and UnitedHealth (NYSE: UNH)

Erin Wright

Morgan Stanley

$409→$375

Buy

31.31%

Upside

Reiterated

01/28/26

UnitedHealth: Buy Rating Reaffirmed on Resilient Earnings, Margin Discipline, and Long-Term Growth Despite Medicare Policy Headwinds

Michael Wiederhorn

Oppenheimer

$415→$385

Buy

34.81%

Upside

Reiterated

01/28/26

UnitedHealth price target lowered to $385 from $415 at OppenheimerUnitedHealth price target lowered to $385 from $415 at Oppenheimer

David Windley

Jefferies

$340

Buy

19.05%

Upside

Reiterated

01/28/26

Jefferies Sticks to Their Buy Rating for UnitedHealth (UNH)

A.J. Rice

UBS

$430→$410

Buy

43.56%

Upside

Reiterated

01/28/26

UnitedHealth price target lowered to $410 from $430 at UBSUnitedHealth price target lowered to $410 from $430 at UBS

Sarah James

Cantor Fitzgerald

$440

Buy

54.07%

Upside

Reiterated

01/28/26

Cantor Fitzgerald Keeps Their Buy Rating on UnitedHealth (UNH)

Matthew Gillmor CFA

KeyBanc

$400

Buy

40.06%

Upside

Reiterated

01/28/26

Analysts Offer Insights on Healthcare Companies: UnitedHealth (NYSE: UNH), HCA Healthcare (NYSE: HCA) and Cardiff Oncology (NASDAQ: CRDF)

Ben Hendrix

RBC Capital

$408→$361

Buy

26.40%

Upside

Reiterated

01/27/26

Analysts' Top Healthcare Picks: AbbVie (ABBV), Maze Therapeutics, Inc. (MAZE)

Kevin Fischbeck

Bank of America Securities

$410→$315

Hold

10.30%

Upside

Reiterated

01/27/26

2027 rate notice likely pushing UnitedHealth lower, says BofA2027 rate notice likely pushing UnitedHealth lower, says BofA

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering UnitedHealth

3 Months

xxx

Success Rate

29/44 ratings generated profit

Average Return

+5.55%

reiterated a xxx

rating 7 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 65.91% of your transactions generating a profit, with an average return of +5.55% per trade.

1 Year

Scott FidelGoldman Sachs

Success Rate

35/43 ratings generated profit

Average Return

+20.98%

reiterated a buy rating 3 months ago

Copying Scott Fidel's trades and holding each position for 1 Year would result in 81.40% of your transactions generating a profit, with an average return of +20.98% per trade.

2 Years

xxx

Success Rate

38/44 ratings generated profit

Average Return

+43.65%

reiterated a xxx

rating 7 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 86.36% of your transactions generating a profit, with an average return of +43.65% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

UNH Analyst Recommendation Trends

Rating

Oct 25

Nov 25

Dec 25

Jan 26

Feb 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, UNH has received 28 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. UNH average Analyst price target in the past 3 months is 372.94.

Each month's total comprises the sum of three months' worth of ratings.

UNH Financial Forecast

UNH Earnings Forecast

Next quarter’s earnings estimate for UNH is $6.80 with a range of $5.01 to $7.76. The previous quarter’s EPS was $2.11. UNH beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year UNH has Performed in-line its overall industry.

UNH Sales Forecast

Next quarter’s sales forecast for UNH is $109.84B with a range of $106.91B to $114.00B. The previous quarter’s sales results were $113.22B. UNH beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year UNH has Performed in-line its overall industry.

UNH Stock Forecast FAQ

What is UNH’s average 12-month price target, according to analysts?

Based on analyst ratings, UnitedHealth’s 12-month average price target is 372.94.

What is UNH’s upside potential, based on the analysts’ average price target?

UnitedHealth has 30.59% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is UNH a Buy, Sell or Hold?

UnitedHealth has a consensus rating of Strong Buy which is based on 16 buy ratings, 2 hold ratings and 0 sell ratings.

What is UnitedHealth’s price target?

The average price target for UnitedHealth is 372.94. This is based on 18 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $440.00 ,the lowest forecast is $311.00. The average price target represents 30.59% Increase from the current price of $285.59.

What do analysts say about UnitedHealth?

UnitedHealth’s analyst rating consensus is a Strong Buy. This is based on the ratings of 18 Wall Streets Analysts.

How can I buy shares of UNH?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

UnitedHealth (UNH) Stock Forecast & Price Target

UNH Analyst Ratings

UNH Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering UnitedHealth

UNH Analyst Recommendation Trends

UNH Financial Forecast

UNH Earnings Forecast

UNH Sales Forecast

UNH Stock Forecast FAQ

Detailed List of Analyst Forecasts